| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.34▼ | 1.33▼ | 1.33▼ | 1.24▲ | 1.22▲ |
| MA10 | 1.33▼ | 1.33▼ | 1.31▲ | 1.23▲ | 1.32▲ |
| MA20 | 1.33▼ | 1.29▲ | 1.27▲ | 1.20▲ | 1.34▼ |
| MA50 | 1.28▲ | 1.23▲ | 1.23▲ | 1.37▼ | 1.29▲ |
| MA100 | 1.24▲ | 1.22▲ | 1.20▲ | 1.33▼ | 1.23▲ |
| MA200 | 1.22▲ | 1.21▲ | 1.25▲ | 1.23▲ | 35,522.84▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | 0.001▲ | 0.006▲ | 0.021▲ | 0.271▲ |
| RSI | 51.845▲ | 61.133▲ | 62.430▲ | 55.992▲ | 32.252▼ |
| STOCH | 52.778 | 71.528 | 85.558▲ | 53.001 | 22.754 |
| WILL %R | -100.000▼ | -33.333 | -25.000 | -13.228▲ | -64.574 |
| CCI | -97.222 | 38.155 | 63.675 | 220.923▲ | -43.084 |
|
Thursday, July 30, 2026 08:57 AM
Allstate reaches a fresh market high as stronger earnings, pricing discipline, dividend stability, and improved underwriting reshape its insurance outlook.
|
|
Tuesday, July 28, 2026 02:21 PM
Allstate’s upcoming earnings call may clarify claims trends, insurance pricing, customer retention, capital discipline, and property-and-casualty market conditions.
|
|
Tuesday, July 07, 2026 05:00 AM
Allarity Therapeutics, Inc. Allarity Therapeutics is now poised to run its DRP® testing in-house in a CLIA-certified laboratory environment. The FDA requires that biomarker testi ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/08/26 | 1.31 | 1.35 | 1.29 | 1.32 | 111,167 |
| 03/08/26 | 1.23 | 1.30 | 1.23 | 1.27 | 63,596 |
| 31/07/26 | 1.21 | 1.24 | 1.1905 | 1.21 | 39,370 |
| 30/07/26 | 1.195 | 1.24 | 1.1701 | 1.23 | 55,393 |
| 29/07/26 | 1.2375 | 1.2375 | 1.1488 | 1.16 | 55,688 |
| 28/07/26 | 1.20 | 1.2599 | 1.16 | 1.18 | 81,702 |
| 27/07/26 | 1.19 | 1.25 | 1.19 | 1.23 | 24,465 |
| 24/07/26 | 1.23 | 1.245 | 1.18 | 1.19 | 39,464 |
| 23/07/26 | 1.288 | 1.288 | 1.215 | 1.22 | 44,679 |
| 22/07/26 | 1.22 | 1.28 | 1.21 | 1.28 | 54,374 |
|
|
||||
|
|
||||
|
|